Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-054710

EVP and General Counsel sold 10,000 shares at $95.00 ($950,000)

  • EVP and General Counsel acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-08 Exercise or conversion : show line 1 in the form +10,000 $54.50 $545,000 34,293 D
2020-10-08 Sale : show line 2 in the form −10,000 $95.00 $950,000 24,293 D
Open-market sales · 10,000 sh · avg $95.00 · $950,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-10-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 $54.50 2026-06-20 10,000 35,000 D
Loading xslF345X03/doc4.xml…